DMCRX vs. NCLEX
Compare and contrast key facts about Driehaus Micro Cap Growth Fund (DMCRX) and Nicholas Limited Edition Fund (NCLEX).
DMCRX is managed by Driehaus. It was launched on Nov 18, 2013. NCLEX is managed by Nicholas. It was launched on May 18, 1987.
Performance
DMCRX vs. NCLEX - Performance Comparison
Loading graphics...
DMCRX vs. NCLEX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
DMCRX Driehaus Micro Cap Growth Fund | 2.25% | 31.17% | 30.58% | 11.47% | -33.54% | 22.23% | 86.43% | 34.03% | 2.52% | 24.35% |
NCLEX Nicholas Limited Edition Fund | -13.00% | -10.41% | 11.91% | 17.17% | -23.71% | 19.07% | 22.67% | 27.36% | -0.94% | 19.93% |
Returns By Period
In the year-to-date period, DMCRX achieves a 2.25% return, which is significantly higher than NCLEX's -13.00% return. Over the past 10 years, DMCRX has outperformed NCLEX with an annualized return of 20.60%, while NCLEX has yielded a comparatively lower 6.82% annualized return.
DMCRX
- 1D
- 5.47%
- 1M
- -7.35%
- YTD
- 2.25%
- 6M
- 10.59%
- 1Y
- 65.25%
- 3Y*
- 24.24%
- 5Y*
- 6.42%
- 10Y*
- 20.60%
NCLEX
- 1D
- 1.71%
- 1M
- -8.10%
- YTD
- -13.00%
- 6M
- -15.05%
- 1Y
- -16.29%
- 3Y*
- -1.57%
- 5Y*
- -2.35%
- 10Y*
- 6.82%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
DMCRX vs. NCLEX - Expense Ratio Comparison
DMCRX has a 1.38% expense ratio, which is higher than NCLEX's 0.85% expense ratio.
Return for Risk
DMCRX vs. NCLEX — Risk / Return Rank
DMCRX
NCLEX
DMCRX vs. NCLEX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Driehaus Micro Cap Growth Fund (DMCRX) and Nicholas Limited Edition Fund (NCLEX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| DMCRX | NCLEX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 2.06 | -0.79 | +2.85 |
Sortino ratioReturn per unit of downside risk | 2.60 | -1.07 | +3.67 |
Omega ratioGain probability vs. loss probability | 1.34 | 0.88 | +0.46 |
Calmar ratioReturn relative to maximum drawdown | 3.73 | -0.73 | +4.46 |
Martin ratioReturn relative to average drawdown | 12.46 | -1.99 | +14.45 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| DMCRX | NCLEX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.06 | -0.79 | +2.85 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.16 | -0.12 | +0.28 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.61 | 0.36 | +0.25 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.54 | 0.50 | +0.03 |
Correlation
The correlation between DMCRX and NCLEX is 0.83, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
DMCRX vs. NCLEX - Dividend Comparison
DMCRX's dividend yield for the trailing twelve months is around 13.42%, more than NCLEX's 8.66% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
DMCRX Driehaus Micro Cap Growth Fund | 13.42% | 13.72% | 3.86% | 0.87% | 8.20% | 48.23% | 19.79% | 14.70% | 33.22% | 8.91% | 0.00% | 4.20% |
NCLEX Nicholas Limited Edition Fund | 8.66% | 7.53% | 2.51% | 2.43% | 6.22% | 16.44% | 5.10% | 5.66% | 10.72% | 7.97% | 10.68% | 8.05% |
Drawdowns
DMCRX vs. NCLEX - Drawdown Comparison
The maximum DMCRX drawdown since its inception was -59.16%, which is greater than NCLEX's maximum drawdown of -48.68%. Use the drawdown chart below to compare losses from any high point for DMCRX and NCLEX.
Loading graphics...
Drawdown Indicators
| DMCRX | NCLEX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -59.16% | -48.68% | -10.48% |
Max Drawdown (1Y)Largest decline over 1 year | -15.46% | -21.36% | +5.90% |
Max Drawdown (5Y)Largest decline over 5 years | -59.16% | -28.50% | -30.66% |
Max Drawdown (10Y)Largest decline over 10 years | -59.16% | -35.79% | -23.37% |
Current DrawdownCurrent decline from peak | -10.79% | -27.21% | +16.42% |
Average DrawdownAverage peak-to-trough decline | -20.35% | -8.21% | -12.14% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.62% | 7.84% | -3.22% |
Volatility
DMCRX vs. NCLEX - Volatility Comparison
Driehaus Micro Cap Growth Fund (DMCRX) has a higher volatility of 12.40% compared to Nicholas Limited Edition Fund (NCLEX) at 5.11%. This indicates that DMCRX's price experiences larger fluctuations and is considered to be riskier than NCLEX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| DMCRX | NCLEX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.40% | 5.11% | +7.29% |
Volatility (6M)Calculated over the trailing 6-month period | 23.15% | 12.33% | +10.82% |
Volatility (1Y)Calculated over the trailing 1-year period | 31.42% | 19.73% | +11.69% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 39.55% | 19.47% | +20.08% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 33.88% | 19.16% | +14.72% |